Invention Grant
- Patent Title: DNA vectors, transposons and transposases for eukaryotic genome modification
-
Application No.: US17150878Application Date: 2021-01-15
-
Publication No.: US12054702B2Publication Date: 2024-08-06
- Inventor: Jeremy Minshull , Mark Welch , Sridhar Govindrajan , Maggie Lee , Kate Caves , Jon Ness
- Applicant: DNA TWOPOINTO INC.
- Applicant Address: US CA Newark
- Assignee: DNA TWOPOINTO INC.
- Current Assignee: DNA TWOPOINTO INC.
- Current Assignee Address: US CA Newark
- Agency: Alston & Bird LLP
- The original application number of the division: US15287622 2016.10.06
- Main IPC: C12N9/00
- IPC: C12N9/00 ; A61K8/66 ; A61K47/42 ; C07K14/435 ; C12N1/16 ; C12N1/18 ; C12N9/12 ; C12N15/10 ; C12N15/52 ; C12N15/62 ; C12N15/63 ; C12N15/81 ; C12N15/85 ; C12N15/90 ; C12N15/67 ; C12R1/84 ; C12R1/865

Abstract:
The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery.
Public/Granted literature
- US20210139919A1 DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION Public/Granted day:2021-05-13
Information query